期刊
CELL CYCLE
卷 7, 期 11, 页码 1564-1568出版社
TAYLOR & FRANCIS INC
DOI: 10.4161/cc.7.11.6054
关键词
HSP90; cancer; cell surface; HER-2; invasion
类别
Heat shock protein 90 (HSP90) is a highly conserved molecular chaperone, assisting intracellularly in the folding and conformational regulation of a multitude of client proteins that play a crucial role in growth, cell survival and developmental processes.(1) Moreover HSP90 interacts with a great number of molecules that are involved in the development and/or survival of cancer cells, allowing mutant proteins to retain or gain function while permitting cancer cells to tolerate the imbalanced signaling that such oncoproteins create.(2,3) Prime examples include the HER-2 receptor, c-Raf-1, Akt/PKB, CDK4 and mutant p53.(4,5) Highly specific inhibitors of HSP90 have been identified and are currently under clinical evaluation. These include geldanamycin and its derivatives 17-allylamino-17-demethoxygeldanamycin and 17-dimethylaminoethylamino17- demethoxygeldanamycin, which inhibit cancer cell proliferation in vitro and tumor growth in vivo.(6-9) Recently, a pool of HSP90 has been identified at the cell surface, 10,11 where it was shown to be involved in cancer cell invasion.(10,12-14) Here, we propose a model concerning the molecular mechanism underlying the role of HSP90 in cancer cell invasion. We suggest that surface HSP90 interacts specifically with the extracellular domain of HER-2 and that this interaction is necessary for the receptor's activation and heterodimerization with ErbB-3, which in turn will mediate signal transduction pathways via MAPK and PI3K-Akt, leading to actin re-arrangement and cell motility. Furthermore we propose that the selective inhibition of cell surface HSP90 with a cell-impermeable function blocking monoclonal antibody, mAb 4C5, may have clinical benefits in limiting cancer cell invasion and metastasis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据